| |
Latest 10 SEC filings (by transaction date) for ABUS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 5/24 | Feb 2/24 | Sims Karen | Direct Ownership | Common Shares | S - Open market or private sale | -4,358 | $2.31 |
Feb 5/24 | Feb 2/24 | Hastings David C | Direct Ownership | Common Shares | S - Open market or private sale | -9,593 | $2.31 |
Feb 5/24 | Feb 2/24 | Sofia Michael J. | Direct Ownership | Common Shares | S - Open market or private sale | -9,982 | $2.31 |
Feb 5/24 | Feb 2/24 | McElhaugh Michael J. | Direct Ownership | Common Shares | S - Open market or private sale | -10,164 | $2.31 |
Feb 5/24 | Feb 1/24 | Naftzger J. Christopher | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 380,500 | |
Feb 5/24 | Feb 1/24 | Naftzger J. Christopher | Direct Ownership | Common Shares | A - Grant, award or other under Rule 16b-3(d) | 95,100 | |
Feb 5/24 | Feb 1/24 | Sims Karen | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 403,900 | |
Feb 5/24 | Feb 1/24 | Sims Karen | Direct Ownership | Common Shares | A - Grant, award or other under Rule 16b-3(d) | 101,000 | |
Feb 5/24 | Feb 1/24 | Hastings David C | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 450,000 | |
Feb 5/24 | Feb 1/24 | Hastings David C | Direct Ownership | Common Shares | A - Grant, award or other under Rule 16b-3(d) | 112,500 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ABUS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 5/24 | Feb 1/24 | Naftzger J. Christopher | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 380,500 | |
Feb 5/24 | Feb 1/24 | Naftzger J. Christopher | Direct Ownership | Common Shares | A - Grant, award or other under Rule 16b-3(d) | 95,100 | |
Feb 5/24 | Feb 1/24 | Sims Karen | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 403,900 | |
Feb 5/24 | Feb 2/24 | Sims Karen | Direct Ownership | Common Shares | S - Open market or private sale | -4,358 | $2.31 |
Feb 5/24 | Feb 1/24 | Sims Karen | Direct Ownership | Common Shares | A - Grant, award or other under Rule 16b-3(d) | 101,000 | |
Feb 5/24 | Feb 1/24 | Hastings David C | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 450,000 | |
Feb 5/24 | Feb 2/24 | Hastings David C | Direct Ownership | Common Shares | S - Open market or private sale | -9,593 | $2.31 |
Feb 5/24 | Feb 1/24 | Hastings David C | Direct Ownership | Common Shares | A - Grant, award or other under Rule 16b-3(d) | 112,500 | |
Feb 5/24 | Feb 1/24 | Sofia Michael J. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 437,800 | |
Feb 5/24 | Feb 2/24 | Sofia Michael J. | Direct Ownership | Common Shares | S - Open market or private sale | -9,982 | $2.31 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Intra-Cellular Therapies (OQ:ITCI) |
Apellis Pharmaceuticals (OQ:APLS) |
Biomarin Pharmaceutical (OQ:BMRN) |